Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion type Assertion NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_head.
- NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion description "[Therapeutic angiogenesis with phVEGF165 gene transfer, if instituted before the development of forefoot gangrene, may provide a novel therapy for patients with advanced Buerger's disease that is unresponsive to standard medical or surgical treatment methods.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_provenance.
- NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion evidence source_evidence_literature NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_provenance.
- NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion SIO_000772 9845647 NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_provenance.
- NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion wasDerivedFrom befree-20140225 NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_provenance.
- NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_assertion wasGeneratedBy ECO_0000203 NP353627.RA5-rHNm91KH8nGK3NeK-1OdaR5E-6JRTg5-WMRgvMoHY130_provenance.